First-of-a-kind service for healthcare professionals will offer access to latest news from leading international transplantation congress.
Transplant TODAY online service will be launched at this month’s International Congress of the Transplantation Society (TTS).
Sandoz, the leading global supplier of generic transplantation medicines, collaborates with international experts to offer this service.
Holzkirchen, August 9, 2016 – Sandoz today announces the launch of a novel online medical education platform, Transplant TODAY, offering access to latest news from the 26th International Congress of The Transplantation Society (TTS2016).
TTS2016 will be held in Hong Kong, starting on August 21. It is a leading international event for physicians, surgeons and scientists specialised in transplantation. Sandoz is the leading global supplier of generic transplantation medicines.
“Transplant TODAY is a one-of-a-kind service for healthcare professionals,” says Dr. Lakhdar Saada, Sandoz Head of Global Medical Affairs, Transplantation. “We are delighted to present this medical education service to the transplant community. Thanks to our collaboration with renowned experts in the field of transplantation, we hope this service will be of great relevance to physicians everywhere.”
Renowned European physicians will analyse latest study results from various congress streams and summarise the findings in English on camera. Physicians can access video presentations and related slide decks on www.transplant-today.com from August 21, 2016 (4 pm CET). They will cover important topics including Kidney & Pancreas, Liver & Intestine, Heart & Lung, Basic Science and Expanding Donor Pool, with a focus on patient care. The presentations can be downloaded on demand and are free of charge.
Transplant TODAY is a medical education initiative supported by Sandoz. The project brings together transplant experts from countries including Germany, Belgium, France, Sweden and the UK. The platform aims to provide physicians from the field of transplantation open access to relevant scientific developments in their field of specialization. Transplant TODAY can be accessed on www.transplant-today.com. In addition, users can sign up for a daily Transplant TODAY newsfeed. Sandoz is committed to playing a key role in achieving global healthcare goals, by pioneering new approaches to drive increased global access to medicines, medical information and medical capacity. This new initiative shows our commitment to developing new ways of expanding access to medical information, to benefit both doctors and patients.
About Sandoz Sandoz is a global leader in generic pharmaceuticals and biosimilars. As a division of the Novartis Group, our purpose is to discover new ways to improve and extend people’s lives. We contribute to society’s ability to support growing healthcare needs by pioneering novel approaches to help people around the world access high-quality medicine. Our portfolio of approximately 1000 molecules, covering all major therapeutic areas, accounted for 2015 sales of USD 10.1 billion. In 2015, our products reached more than 500 million patients and we aspire to reach one billion. Sandoz is headquartered in Holzkirchen, in Germany’s Greater Munich area.